0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Sign in to save

Uncovering the Hidden Risks: How PLA and PLGA Microplastics Disrupt Gut Microbiota and Metabolic Health

Chemical Research in Toxicology 2026
Bei Gao, L Chen, Weichen Xu, Guangyuan Liu, Mengru Wei, Weishou Shen, Pengcheng Tu, Jinjun Shan

Summary

Even "biodegradable" plastics aren't necessarily safe for your gut: this study found that microplastics from PLA and PLGA (common plant-based plastics used in things like food packaging and medical devices) disrupted gut bacteria and altered metabolism in ways that affected the liver and bloodstream. Each type of plastic caused its own unique problems, but both disrupted several of the same important body processes, including how the body handles amino acids and fats. This matters because "biodegradable" plastics are often marketed as eco-friendly alternatives, but this research suggests we shouldn't assume they're automatically better for our health.

Polymers
Body Systems

-glycolic acid) (PLGA) have been widely adopted across various industries. While the toxicity of PLA microplastics has been studied extensively, the biological effects of PLGA microplastics remain largely unknown. Through metagenomic sequencing and untargeted metabolomic profiling, we evaluated the impacts of both PLA and PLGA microplastics on gut bacteria, fungi, virulence factors, microbial metabolic pathways, and metabolites in feces, serum, and liver tissue in this study. Our results demonstrate that both types of biodegradable microplastics disrupt gut microbiota and host metabolic homeostasis. PLA exposure provoked more pronounced changes in gut bacteria, fungi, virulence factors, and fecal and hepatic metabolites. In contrast, microbial metabolic pathways and serum metabolites were more strongly affected by PLGA. Several altered features were common to both microplastics, including enrichment of hepatic metabolic pathways related to valine, leucine, and isoleucine biosynthesis; one-carbon pool by folate; glycine, serine, and threonine metabolism; pantothenate and CoA biosynthesis; taurine and hypotaurine metabolism; and cysteine and methionine metabolism. Other disturbances were material-specific, such as UMP biosynthesis pathways, which were altered exclusively by PLA, while palmitate biosynthesis and unsaturated fatty acid biosynthesis were affected only by PLGA. These findings advance our understanding of the distinct and shared health risks posed by different biodegradable microplastics, providing a clearer basis for assessing their long-term safety.

Share this paper